PortfoliosLab logo
FULC vs. BIOX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between FULC and BIOX is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

FULC vs. BIOX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulcrum Therapeutics, Inc. (FULC) and Bioceres Crop Solutions Corp. (BIOX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

FULC:

95.33%

BIOX:

75.22%

Max Drawdown

FULC:

-11.52%

BIOX:

-1.44%

Current Drawdown

FULC:

-6.28%

BIOX:

0.00%

Fundamentals

Market Cap

FULC:

$289.87M

BIOX:

$284.73M

EPS

FULC:

-$0.01

BIOX:

$0.02

PS Ratio

FULC:

3.62

BIOX:

0.70

PB Ratio

FULC:

1.20

BIOX:

0.80

Total Revenue (TTM)

FULC:

$80.00M

BIOX:

$323.71M

Gross Profit (TTM)

FULC:

$62.74M

BIOX:

$128.40M

EBITDA (TTM)

FULC:

-$6.35M

BIOX:

$34.00M

Returns By Period


FULC

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

BIOX

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FULC vs. BIOX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FULC
The Risk-Adjusted Performance Rank of FULC is 4141
Overall Rank
The Sharpe Ratio Rank of FULC is 3636
Sharpe Ratio Rank
The Sortino Ratio Rank of FULC is 4848
Sortino Ratio Rank
The Omega Ratio Rank of FULC is 5050
Omega Ratio Rank
The Calmar Ratio Rank of FULC is 3232
Calmar Ratio Rank
The Martin Ratio Rank of FULC is 4040
Martin Ratio Rank

BIOX
The Risk-Adjusted Performance Rank of BIOX is 55
Overall Rank
The Sharpe Ratio Rank of BIOX is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of BIOX is 33
Sortino Ratio Rank
The Omega Ratio Rank of BIOX is 44
Omega Ratio Rank
The Calmar Ratio Rank of BIOX is 55
Calmar Ratio Rank
The Martin Ratio Rank of BIOX is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FULC vs. BIOX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulcrum Therapeutics, Inc. (FULC) and Bioceres Crop Solutions Corp. (BIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

FULC vs. BIOX - Dividend Comparison

Neither FULC nor BIOX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

FULC vs. BIOX - Drawdown Comparison

The maximum FULC drawdown since its inception was -11.52%, which is greater than BIOX's maximum drawdown of -1.44%. Use the drawdown chart below to compare losses from any high point for FULC and BIOX. For additional features, visit the drawdowns tool.


Loading data...

Volatility

FULC vs. BIOX - Volatility Comparison


Loading data...

Financials

FULC vs. BIOX - Financials Comparison

This section allows you to compare key financial metrics between Fulcrum Therapeutics, Inc. and Bioceres Crop Solutions Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M202120222023202420250
106.80M
(FULC) Total Revenue
(BIOX) Total Revenue
Values in USD except per share items